Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CK0802 in Steroid Refractory Graft vs. Host Disease
NCT07576699Phase 2Not yet recruiting
- Start
- Nov 2026
- Primary completion
- Jun 2028
- Modality
- Regulatory T Cells (Tregs)
01
Overview
A Phase 2 trial of CK0802 in Acute Graft-Versus-Host Disease (aGVHD). Planned start Nov 2026; status: not yet recruiting.
02
Drugs
CK0802
03
Conditions
Acute Graft-Versus-Host Disease (aGVHD)
Beyond the preview
Go deeper on NCT07576699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07576699.